Skip to main content
RxCopaysGet started

Neurofibromatosis type 1

Rare

Genetic Disorder

Neurofibromatosis type 1 is treated with 1 medication in our database, including KOSELUGO. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by AstraZeneca. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Neurofibromatosis type 1 treatment below.

What help exists for Neurofibromatosis type 1

2

drugs indexed

2

with copay cards

2

with patient assistance

16

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Neurofibromatosis type 1

2 total

🎟 = copay card · 💙 = patient assistance program

Prior authorization patterns for Neurofibromatosis type 1 drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

—

Medicare Part D

Yes——

—

Medicare Part D

———

Grants for Neurofibromatosis type 1 patients

25 total · 16 open

Neurofibromatosis type 1 is a rare disease — more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare →